Metformin vs Acarbose
Written by Aaron CuhaReviewed Sep 2026
The short answer
Two old, cheap diabetes pills with very different reputations among longevity fans. Acarbose gave one of the largest lifespan gains in male mice, in the mouse program built to catch false alarms. Metformin's record in ageing research keeps finding nothing. In people, the two have been compared directly, but only on blood sugar.
- Metformin people
- 489
- Metformin nulls
- 0
- Acarbose people
- 0
- Acarbose nulls
- 0
Dose
Approved medicine. No human dose established for unlabelled uses
Labeled amounts sit on the prescribing information. This page records what trials measured, not a personal dose.
FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity.
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
2 human studies where nobody was given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
MetforminMetformin hydrochloride (biguanide)
A cheap, very safe diabetes drug that many people take hoping to live longer. Big studies in people have not shown it helps with ageing. It also takes the edge off the muscle and fitness you gain from training.
Column B
AcarboseAcarbose (alpha-glucosidase inhibitor)
An old, cheap diabetes pill that slows how fast starch turns into sugar. In people, a large heart study found no heart benefit, and it has never been tested for ageing. In the US government's mouse program, it made male mice live 6 to 22 percent longer.
These two were tested against each other in the same trial
One trial gave people each of them. This is not us lining up two separate records.
HbA1c fell 1.17 percent on acarbose and 1.19 percent on metformin at week 24. At week 48 the drops were 1.11 and 1.12 percent, a gap of 0.01 percentage points, which is no real difference. Serious side effects hit 2 percent of each group, and low blood sugar episodes 1 percent of each.
What the trial was
A 48 week study at 11 sites in China. Everyone knew which drug they got. 788 patients with newly found type 2 diabetes and an average HbA1c of 7.5 percent first had four weeks of diet and lifestyle changes. Then they got 24 weeks of metformin alone or acarbose alone, followed by 24 weeks where extra drugs were allowed if blood sugar targets were missed. The goal was to show acarbose was no worse, allowing a gap of up to 0.3 percentage points.
What the authors concluded
The authors conclude that acarbose works about as well as metformin and so is a real choice for first treatment in Chinese patients with newly found type 2 diabetes.
Where this result is weak
This is a blood sugar trial, not an ageing trial. Nothing in it speaks to the mouse lifespan result that draws people to acarbose. Everyone knew which drug they got, it ran 48 weeks, and it enrolled only Chinese patients. Their high starch diet may well favour a drug that blocks starch digestion. It was paid for by Bayer, which makes acarbose. And allowing extra drugs after week 24 blurs what the second half measures.
MARCH (ChiCTR-TRC-08000231), Lancet Diabetes and Endocrinology, 2014
Side by side, on the facts we can check
| What we compare | Metformin | Acarbose |
|---|---|---|
| Category | Longevity | Longevity |
| FDA status | FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity. | Approved for type 2 diabetes. The original US brand was discontinued and generic versions are sold. In Canada, the original brand was taken off the market in 2023, and a generic is available. |
| Half-life | 4 to 9 hours (plasma), longer in erythrocytes | About 2 hours; acts locally in the gut with minimal systemic absorption |
| Molecular weight | 129.2 Da (165.6 Da as hydrochloride) | 645.6 Da |
| How it works | It blocks part of the energy machinery in mitochondria, called complex I, and switches on AMPK, a fuel sensor. That makes the liver release less sugar and helps the body respond to insulin. The AMPK story is not the whole answer. Research groups still argue over how much comes from complex I, from another enzyme called mitochondrial glycerophosphate dehydrogenase, and from effects in the gut. | It blocks gut enzymes called alpha-glucosidases, so complex carbs break down more slowly and blood sugar rises less after a meal. The undigested carbs reach the large bowel, where gut bacteria ferment them. That causes the usual side effects, and it may also add to the effect on blood sugar and body chemistry. |
| Studies in people | 7 | 2 |
| Evidence | Moderate: 3 completed trials, 489 people given it | Preliminary: 2 human studies where nobody was given it |
| Legal status, US | Prescription only; approved for type 2 diabetes | Prescription only; approved for type 2 diabetes |
Frequently asked questions
What is the difference between Metformin and Acarbose?
Metformin: A cheap, very safe diabetes drug that many people take hoping to live longer. Big studies in people have not shown it helps with ageing. It also takes the edge off the muscle and fitness you gain from training. Acarbose: An old, cheap diabetes pill that slows how fast starch turns into sugar. In people, a large heart study found no heart benefit, and it has never been tested for ageing. In the US government's mouse program, it made male mice live 6 to 22 percent longer.
Which has stronger research evidence, Metformin or Acarbose?
Each compound gets a band worked out from facts we counted, with the math shown. Metformin is Moderate (3 completed trials, 489 people given it). Acarbose is Preliminary (2 human studies where nobody was given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Metformin and Acarbose FDA-approved?
Metformin: FDA approved for type 2 diabetes since 1994. Not approved for ageing or longevity.. Acarbose: Approved for type 2 diabetes. The original US brand was discontinued and generic versions are sold. In Canada, the original brand was taken off the market in 2023, and a generic is available..
Related posts
Blog articles that cover Metformin or Acarbose, newest first.
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.